Luca Boldrini

Università Cattolica del Sacro Cuore, Roma, Italia

Luca Boldrini obtained his Medical Degree and completed his residency program in Radiotherapy at the Università Cattolica del Sacro Cuore of Rome, Italy. 

He currently works as Radiation Oncologist at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS - Università Cattolica del Sacro Cuore of Rome, where he is involved in the MRI guided radiotherapy research program.

His primary research interests include MRI guided radiotherapy, radiomics, imaging applications in the frame of personalised medicine and innovative technologies implementation in cancer care.

He is author of numerous scientific publication, books, and e-publications. 
He is clinical coordinator of the radiomics research program of the Knowledge Based Oncology Lab (KBO Lab) of Rome, Italy.

He is currently a Ph.D. student in Oncological Sciences focusing on “Radiation Oncology, imaging and technological innovation” at the Università Cattolica del Sacro Cuore of Rome, Italy and member of several national and
international scientific associations.

dont miss

Radiomics applications rectal cancer: the MRIdian perspective

The seminar will describe the potentialities of low T MRI guided hybrid Radiotherapy from a radiomics perspective. The talk will be focused on radiomics based prediction models for complete clinical response in rectal cancer patients undergoing neoadjuvant chemoradiotherapy.

EVEN MORE SEMINARS

  • Arie Parnham: Speaking at the Oncology Convention

    Arie Parnham
    The Christie NHS Foundation Trust

    Penile sparing and minimally invasive techniques for penile cancer

  • Khurum Khan: Speaking at the Oncology Convention

    Khurum Khan
    Royal Marsden NHS Foundation Trust

    Biomarkers of response and/or resistance to targeted therapies in refractory mCRC

  • Joanne Edwards: Speaking at the Oncology Convention

    Joanne Edwards
    University of Glasgow

    Role of IKK alpha in Breast Cancer

  • DR Zayad Ratansi: Speaking at the Oncology Convention

    DR Zayad Ratansi
    o3 Health Ltd

    Hyperbarics within Oncology

  • Corina van den Hurk: Speaking at the Oncology Convention

    Corina van den Hurk
    Netherlands Comprehensive Cancer Organisation

    Hair loss through chemotherapy is not inevitable!